We are live on ! Find out more
CODX icon

Co-Diagnostics

77 hedge funds and large institutions have $63.7M invested in Co-Diagnostics in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 32 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 17

1% less funds holding

Funds holding: 78 → 77 (-1)

2.97% less ownership

Funds ownership: 27.65% → 24.69% (-3%)

22% less call options, than puts

Call options by funds: $5.6M | Put options by funds: $7.19M

44% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 32

58% less capital inflows, than outflows

Capital inflows: $5.78M | Capital outflows: $13.8M

Holders
77
Holders Change
-1
Holders Change %
-1.28%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
18
Reduced
32
Closed
17
Calls
$5.6​M
Puts
$7.19​M
Net Calls
-⁠$1.58​M
Net Calls Change
+$466​K

CODX Hedge Fund Activity: Q4 2021 in Review

77 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q4 2021, worth a combined $63.7M — down 18% from $77.6M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CODX and 16 opened new positions — a net loss of 1 holder — while 32 trimmed existing stakes and 18 added.

The largest buyer was Renaissance Technologies, adding an estimated $962K. The largest seller was Marshall Wace, exiting entirely with an estimated $2.15M sold.

  • 77 institutional investors held Co-Diagnostics (CODX) as of Q4 2021, down from 78 in Q3 2021.
  • Funds reported $63.7M of Co-Diagnostics stock for Q4 2021, down 18% quarter-over-quarter.
  • 16 funds opened new Co-Diagnostics positions in Q4 2021 and 17 closed out, a net change of -1 holder.
  • The largest Co-Diagnostics buyer in Q4 2021 was Renaissance Technologies, an estimated $962K added.
  • The largest Co-Diagnostics seller in Q4 2021 was Marshall Wace, an estimated $2.15M sold.

Based on aggregated 13F filings for Q4 2021.